Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|3|1|60-66

ISSN： 1574-8863

Source： Current Drug Safety, Vol.3, Iss.1, 2008-01, pp. : 60-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical comparison of weight‐ and age‐based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults

By  

Acta Haematologica, Vol. 132, Iss. 3-4, 2014-09 ,pp. : 313-325

Karger

Access to resources Recommend Favorite

Efficacy of high‐dose steroids for bronchiolitis obliterans syndrome post pediatric hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Leflunomide for the Treatment of BK Virus-Associated Hemorrhagic Cystitis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

By  

Acta Haematologica, Vol. 130, Iss. 1, 2013-02 ,pp. : 52-56

Karger

Access to resources Recommend Favorite

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite